• Company Type For Profit
  • Contact Email info@rhenovia.com
  • Phone Number 33 3 89 32 76 84

Rhenovia Pharma SAS is a French biotechnology company founded in 2007 by an international team that brings together managers from large pharmaceutical companies and world experts in neuroscience and nervous system modeling. The company is the world leader in the application of biosimulation in the prevention and treatment of neurological,

neurodegenerative and psychiatric disorders and diseases. Based in Mulhouse (France) and Cambridge (Massachusetts), Rhenovia has around twenty members of staff in France, Switzerland, Germany and the US.

Lists Featuring This Company

Europe Early Stage Companies With More Than $1M in Revenue
3,373 Number of Organizations â€¢ $79.9B Total Funding Amount â€¢ 18,310 Number of Investors
France Companies With Less Than $10M in Revenue (Top 10K)
9,924 Number of Organizations â€¢ $37.8B Total Funding Amount â€¢ 10,178 Number of Investors
Europe Early Stage Companies With Less Than $10M in Revenue
3,328 Number of Organizations â€¢ $55.9B Total Funding Amount â€¢ 16,247 Number of Investors
France Early Stage Companies
896 Number of Organizations â€¢ $18.2B Total Funding Amount â€¢ 4,428 Number of Investors

Frequently Asked Questions

Where is Rhenovia Pharma's headquarters? Rhenovia Pharma is located in Mulhouse, Alsace, France.Who invested in Rhenovia Pharma? Rhenovia Pharma has 2 investors including Alsace Business Angels and SODIV ALSACE.How much funding has Rhenovia Pharma raised to date? Rhenovia Pharma has raised .When was the last funding round for Rhenovia Pharma? Rhenovia Pharma closed its last funding round on Feb 12, 2014 from a Series B round.Who are Rhenovia Pharma's competitors? Alternatives and possible competitors to Rhenovia Pharma may include Tmunity TherapeuticsSpark Therapeutics, and Aclaris Therapeutics.